• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新陈代谢与炎症的交叉作用由己糖激酶的细胞内拓扑结构和葡萄糖的代谢命运所调控。

The intersection of metabolism and inflammation is governed by the intracellular topology of hexokinases and the metabolic fate of glucose.

作者信息

Codocedo Juan F, Landreth Gary E

机构信息

Stark Neuroscience Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.

Department of Anatomy, Cell Biology and Physiology, Indiana University School of Medicine, Indianapolis, IN, USA.

出版信息

Immunometabolism (Cobham). 2022 Oct 28;4(4):e00011. doi: 10.1097/IN9.0000000000000011. eCollection 2022 Oct.

DOI:10.1097/IN9.0000000000000011
PMID:36337735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9616595/
Abstract

Hexokinases (HKs) catalyze the first and irreversible step of glucose metabolism. Its product, glucose-6-phosphate (G-6P) serves as a precursor for catabolic processes like glycolysis for adenosine 5'-triphosphate (ATP) production and anabolic pathways including the pentose phosphate pathway (PPP) for the generation of intermediaries like nicotinamide adenine dinucleotide phosphate (NADPH) and ribulose-5-P. Thus, the cellular fate of glucose is important not only for growth and maintenance, but also to determine different cellular activities. Studies in immune cells have demonstrated an intimate linkage between metabolic pathways and inflammation, however the precise molecular mechanisms that determine the cellular fate of glucose during inflammation or aging are not completely understood. Here we discuss a study by De Jesus et al that describes the role of HK1 cytosolic localization as a critical regulator of glucose flux by shunting glucose into the PPP at the expense of glycolysis, exacerbating the inflammatory response of macrophages. The authors convincingly demonstrate a novel mechanism that is independent of its mitochondrial functions, but involve the association to a protein complex that inhibits glycolysis at the level of glyceraldehyde 3-phosphate dehydrogenase. We expand the discussion by comparing previous studies related to the HK2 isoform and how cells have evolved to regulate the mitochondrial association of these two isoforms by non-redundant mechanism.

摘要

己糖激酶(HKs)催化葡萄糖代谢的第一步且是不可逆的步骤。其产物葡萄糖-6-磷酸(G-6P)是分解代谢过程(如用于生成三磷酸腺苷(ATP)的糖酵解)和合成代谢途径(包括用于生成烟酰胺腺嘌呤二核苷酸磷酸(NADPH)和5-磷酸核酮糖等中间产物的磷酸戊糖途径(PPP))的前体。因此,葡萄糖的细胞命运不仅对细胞生长和维持很重要,而且对于决定不同的细胞活动也很重要。在免疫细胞中的研究表明代谢途径与炎症之间存在密切联系,然而,在炎症或衰老过程中决定葡萄糖细胞命运的精确分子机制尚未完全了解。在此,我们讨论德赫苏斯等人的一项研究,该研究描述了HK1胞质定位通过将葡萄糖分流至PPP而牺牲糖酵解,从而作为葡萄糖通量的关键调节因子,加剧巨噬细胞的炎症反应。作者令人信服地证明了一种新机制,该机制独立于其线粒体功能,但涉及与一种在3-磷酸甘油醛脱氢酶水平抑制糖酵解的蛋白质复合物的关联。我们通过比较先前与HK2亚型相关的研究以及细胞如何通过非冗余机制进化来调节这两种亚型的线粒体关联来扩展讨论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7312/9616595/e30e0acb9b82/in9-4-e00011-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7312/9616595/e30e0acb9b82/in9-4-e00011-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7312/9616595/e30e0acb9b82/in9-4-e00011-g001.jpg

相似文献

1
The intersection of metabolism and inflammation is governed by the intracellular topology of hexokinases and the metabolic fate of glucose.新陈代谢与炎症的交叉作用由己糖激酶的细胞内拓扑结构和葡萄糖的代谢命运所调控。
Immunometabolism (Cobham). 2022 Oct 28;4(4):e00011. doi: 10.1097/IN9.0000000000000011. eCollection 2022 Oct.
2
Hexokinase 1 cellular localization regulates the metabolic fate of glucose.己糖激酶 1 的细胞定位调节葡萄糖的代谢命运。
Mol Cell. 2022 Apr 7;82(7):1261-1277.e9. doi: 10.1016/j.molcel.2022.02.028. Epub 2022 Mar 18.
3
Proliferating tumor cells mimick glucose metabolism of mature human erythrocytes.增殖的肿瘤细胞模拟成熟人类红细胞的葡萄糖代谢。
Cell Cycle. 2019 Jun;18(12):1316-1334. doi: 10.1080/15384101.2019.1618125. Epub 2019 Jun 3.
4
Loss of hexokinase 1 sensitizes ovarian cancer to high-dose metformin.己糖激酶1的缺失使卵巢癌对高剂量二甲双胍敏感。
Cancer Metab. 2021 Dec 11;9(1):41. doi: 10.1186/s40170-021-00277-2.
5
Should the standard model of cellular energy metabolism be reconsidered? Possible coupling between the pentose phosphate pathway, glycolysis and extra-mitochondrial oxidative phosphorylation.细胞能量代谢的标准模型是否需要重新考虑?戊糖磷酸途径、糖酵解和细胞外氧化磷酸化之间可能存在偶联。
Biochimie. 2024 Jun;221:99-109. doi: 10.1016/j.biochi.2024.01.018. Epub 2024 Feb 1.
6
Subcellular localization of hexokinases I and II directs the metabolic fate of glucose.己糖激酶 I 和 II 的亚细胞定位决定了葡萄糖的代谢命运。
PLoS One. 2011 Mar 9;6(3):e17674. doi: 10.1371/journal.pone.0017674.
7
Regulation of the pentose phosphate pathway in cancer.癌症中磷酸戊糖途径的调控
Protein Cell. 2014;5(8):592-602. doi: 10.1007/s13238-014-0082-8. Epub 2014 Jul 12.
8
HK2/hexokinase-II integrates glycolysis and autophagy to confer cellular protection.己糖激酶2(HK2)整合糖酵解和自噬以赋予细胞保护作用。
Autophagy. 2015;11(6):963-4. doi: 10.1080/15548627.2015.1042195.
9
c-MYC Triggers Lipid Remodelling During Early Somatic Cell Reprogramming to Pluripotency.c-MYC 触发早期体细胞核重编程为多能性过程中的脂质重塑。
Stem Cell Rev Rep. 2021 Dec;17(6):2245-2261. doi: 10.1007/s12015-021-10239-2. Epub 2021 Sep 2.
10
Effect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cells.慢病毒介导的HK1、HK2和HK3基因shRNA失活对结直肠癌和黑色素瘤细胞的影响。
BMC Genet. 2016 Dec 22;17(Suppl 3):156. doi: 10.1186/s12863-016-0459-1.

引用本文的文献

1
Therapeutic targeting of immunometabolism reveals a critical reliance on hexokinase 2 dosage for microglial activation and Alzheimer's progression.免疫代谢治疗靶点揭示了对葡萄糖激酶 2 剂量的关键依赖,以用于小胶质细胞激活和阿尔茨海默病进展。
Cell Rep. 2024 Jul 23;43(7):114488. doi: 10.1016/j.celrep.2024.114488. Epub 2024 Jul 13.
2
Cross-Domain Text Mining of Pathophysiological Processes Associated with Diabetic Kidney Disease.与糖尿病肾病相关的病理生理过程的跨领域文本挖掘
Int J Mol Sci. 2024 Apr 19;25(8):4503. doi: 10.3390/ijms25084503.
3
Therapeutic targeting of immunometabolism in Alzheimer's disease reveals a critical reliance on Hexokinase 2 dosage on microglial activation and disease progression.

本文引用的文献

1
Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBα.有氧糖酵解通过己糖激酶 2 介导的 IκBα 磷酸化促进肿瘤免疫逃逸。
Cell Metab. 2022 Sep 6;34(9):1312-1324.e6. doi: 10.1016/j.cmet.2022.08.002. Epub 2022 Aug 24.
2
The hexokinase "HKDC1" interaction with the mitochondria is essential for liver cancer progression.己糖激酶“HKDC1”与线粒体的相互作用对肝癌的进展至关重要。
Cell Death Dis. 2022 Jul 28;13(7):660. doi: 10.1038/s41419-022-04999-z.
3
Hexokinase 3 enhances myeloid cell survival via non-glycolytic functions.
阿尔茨海默病免疫代谢的治疗靶点揭示了小胶质细胞激活和疾病进展对己糖激酶2剂量的关键依赖。
bioRxiv. 2023 Nov 15:2023.11.11.566270. doi: 10.1101/2023.11.11.566270.
己糖激酶 3 通过非糖酵解功能增强髓样细胞存活。
Cell Death Dis. 2022 May 11;13(5):448. doi: 10.1038/s41419-022-04891-w.
4
Hexokinase 1 cellular localization regulates the metabolic fate of glucose.己糖激酶 1 的细胞定位调节葡萄糖的代谢命运。
Mol Cell. 2022 Apr 7;82(7):1261-1277.e9. doi: 10.1016/j.molcel.2022.02.028. Epub 2022 Mar 18.
5
Microbial regulation of hexokinase 2 links mitochondrial metabolism and cell death in colitis.微生物调控己糖激酶 2 可将线粒体代谢与结肠炎中的细胞死亡相联系。
Cell Metab. 2021 Dec 7;33(12):2355-2366.e8. doi: 10.1016/j.cmet.2021.11.004. Epub 2021 Nov 29.
6
Hexokinase domain-containing protein-1 in metabolic diseases and beyond.己糖激酶结构域蛋白-1 在代谢性疾病及其他领域的研究进展。
Trends Endocrinol Metab. 2022 Jan;33(1):72-84. doi: 10.1016/j.tem.2021.10.006. Epub 2021 Nov 12.
7
Hexokinases inhibit death receptor-dependent apoptosis on the mitochondria.己糖激酶抑制线粒体上死亡受体依赖性细胞凋亡。
Proc Natl Acad Sci U S A. 2021 Aug 17;118(33). doi: 10.1073/pnas.2021175118.
8
Structural basis of complex formation between mitochondrial anion channel VDAC1 and Hexokinase-II.线粒体阴离子通道 VDAC1 与己糖激酶-II 形成复合物的结构基础。
Commun Biol. 2021 Jun 3;4(1):667. doi: 10.1038/s42003-021-02205-y.
9
A hexokinase isoenzyme switch in human liver cancer cells promotes lipogenesis and enhances innate immunity.肝癌细胞中己糖激酶同工酶的转换促进脂肪生成并增强先天免疫。
Commun Biol. 2021 Feb 16;4(1):217. doi: 10.1038/s42003-021-01749-3.
10
Unlocking the Potential of HK2 in Cancer Metabolism and Therapeutics.揭示 HK2 在癌症代谢与治疗中的潜力。
Curr Med Chem. 2019;26(41):7285-7322. doi: 10.2174/0929867326666181213092652.